Log In
Print
BCIQ
Print
Print this Print this
 

NovoThirteen, Tretten, catridecacog, recombinant coagulation Factor XIII A-subunit (rFXIII)

Also known as: NN1841

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionRecombinant analogue of Factor XIII A-subunit
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today